Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
28,854,977
-
Share change
-
-188,617
-
Total reported value
-
$401,952,759
-
Put/Call ratio
-
118%
-
Price per share
-
$13.93
-
Number of holders
-
100
-
Value change
-
-$18,013,419
-
Number of buys
-
51
-
Number of sells
-
46
Institutional Holders of Kiniksa Pharmaceuticals Intern - COM (KNSA) as of Q2 2021
As of 30 Jun 2021,
Kiniksa Pharmaceuticals Intern - COM (KNSA) was held by
100 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
28,854,977 shares.
The largest 10 holders included
PICTET ASSET MANAGEMENT LTD, HHLR ADVISORS, LTD., BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, BlackRock Inc., STATE STREET CORP, Opaleye Management Inc., JANUS HENDERSON GROUP PLC, ArrowMark Colorado Holdings LLC, and Hudson Bay Capital Management LP.
This page lists
100
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.